-
T419195-50μgProduct InfoVial Contents:50 ug of C-terminal peptide (16 -mer) in a lyophilzed form.Material Safety Data:THIS PRODUCT IS NOT LICENSED OR APPROVED FOR ADMINISTRATION TO HUMANS OR TO ANIMALS OTHER THAN EXPERIMENTAL ANIMALS.DescriptionThis vial
-
T118943-10mgTuftsin Tuftsin acetate salt hydrate
-
T118943-25mgTuftsin Tuftsin acetate salt hydrate
-
T118943-5mgTuftsin Tuftsin acetate salt hydrate
-
U118944-0.5mgAmino Acid Sequence Asp-Asn-Pro-Ser-Leu-Ser-I?le-Asp-Leu-Thr-Phe-His-Le?u-Leu-Arg-Thr-Leu-Leu-Glu?-Leu-Ala-Arg-Thr-Gln-Ser-?Gln-Arg-Glu-Arg-Ala-Glu-G?ln-Asn-Arg-Ile-Ile-Phe-As?p-Ser-Val-NH2
-
U118944-1mgAmino Acid Sequence Asp-Asn-Pro-Ser-Leu-Ser-I?le-Asp-Leu-Thr-Phe-His-Le?u-Leu-Arg-Thr-Leu-Leu-Glu?-Leu-Ala-Arg-Thr-Gln-Ser-?Gln-Arg-Glu-Arg-Ala-Glu-G?ln-Asn-Arg-Ile-Ile-Phe-As?p-Ser-Val-NH2
-
U118944-5mgAmino Acid Sequence Asp-Asn-Pro-Ser-Leu-Ser-I?le-Asp-Leu-Thr-Phe-His-Le?u-Leu-Arg-Thr-Leu-Leu-Glu?-Leu-Ala-Arg-Thr-Gln-Ser-?Gln-Arg-Glu-Arg-Ala-Glu-G?ln-Asn-Arg-Ile-Ile-Phe-As?p-Ser-Val-NH2
-
U118947-0.5mgAmino Acid Sequence Phe-Thr-Leu-Ser-Leu-Asp-V?al-Pro-Thr-Asn-Ile-Met-As?n-Leu-Leu-Phe-Asn-Ile-Ala?-Lys-Ala-Lys-Asn-Leu-Arg-?Ala-Gln-Ala-Ala-Ala-Asn-A?la-His-Leu-Met-Ala-Gln-Il?e-NH2
-
U118947-1mgAmino Acid Sequence Phe-Thr-Leu-Ser-Leu-Asp-V?al-Pro-Thr-Asn-Ile-Met-As?n-Leu-Leu-Phe-Asn-Ile-Ala?-Lys-Ala-Lys-Asn-Leu-Arg-?Ala-Gln-Ala-Ala-Ala-Asn-A?la-His-Leu-Met-Ala-Gln-Il?e-NH2
-
U118947-5mgAmino Acid Sequence Phe-Thr-Leu-Ser-Leu-Asp-V?al-Pro-Thr-Asn-Ile-Met-As?n-Leu-Leu-Phe-Asn-Ile-Ala?-Lys-Ala-Lys-Asn-Leu-Arg-?Ala-Gln-Ala-Ala-Ala-Asn-A?la-His-Leu-Met-Ala-Gln-Il?e-NH2
-
U118945-0.5mgEndogenous CRF agonist
-
U118945-1mgEndogenous CRF agonist